Sana Noreen
Lahore, Punjab Province, 54000, Pakistan
NCT Number: NCT07740473
Cinnamon-enriched cookies were developed and evaluated for their sensory acceptability and potential as a functional food for adults with hyperlipidemia. The findings suggest that incorporating cinnamon into cookies alongside conventional therapy may support cardiovascular and liver health while offering a palatable dietary intervention.
Looking for future studies?
Notify Me45 year–55 year
All sexes
Interventional
Not applicable
Lahore, Punjab Province, 54000, Pakistan
This study developed cinnamon-enriched cookies as a functional food and evaluated their sensory acceptability, physical characteristics, and potential health benefits in adults with hyperlipidemia receiving conventional therapy. The findings highlight the potential of cinnamon-enriched cookies as a convenient, acceptable, and food-based dietary strategy to support cardiovascular and liver health, encouraging the development of functional bakery products for managing hyperlipidemia.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Both men and women aged 45-55 participated in the study. The experiment targeted high-cholesterol, triglycerides, and low-density lipoprotein patients (>220, 150, and 130 mg/dL).
Exclusion criteria
Individuals with diabetes, gastrointestinal issues, documented cinnamon allergies were excluded.
-
Conventional therapy + cinnamon-enriched cookie (1 cookie/day)
Time frame: 10 weeks
Weight, BMI was measured
Time frame: 10 weeks
Lipid Profile was observed
Time frame: 10 weeks
Liver Enzymes were observed
University of Lahore
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00328523
Dyslipidemias, Hypercholesterolaemia
View Trial DetailsNCT06890546
Body Weight, Dyslipidemias
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT05233917
Dyslipidemias, Glucose Metabolism Disorders
Jinhua, Zhejiang, China
View Trial DetailsNCT04964557
Dyslipidemias, Hyperlipidaemia
Huntsville, Alabama, United States
View Trial Details